Investors
Management Team.
The company’s stock symbol is HXBM.OB. For a complete listing of reports and filings please visit the Securities and Exchange Commission at www.sec.gov…click to learn more
Management Team…click to learn more.
Board of Directors…click to learn more.
The Management and Board of Directors of Helix BioMedix Inc. are committed to operating the company in an efficient, compliant and ethical manner, thereby improving our ability for growth and creation of value for our stockholders…click to learn more.
Helix BioMedix, Inc. is pleased to offer the following online services…click to learn more.

Online Access to Annual Report and Proxy Statement
Electronic Proxy Voting
Beneficial Stockholders
Registered Stockolders

Management Team

R.Stephen Beatty, Chief Executive Officer & Chairman of the Board
R. Stephen Beatty is Chief Executive Officer. He was appointed as Chairman of the Board in February 2015 and has served on the Board of Directors since May 1999. Prior to joining the Company, Mr. Beatty established and operated Beatty Finance, Inc., a private financial services company serving the legal profession. Prior to founding Beatty Finance, Inc., Mr. Beatty worked with BellSouth where he managed one of BellSouth’s corporate re-engineering teams, directed the development of enterprise software for BellSouth’s marketing division and was a member of BellSouth’s “Future Thinkers”, an in-house corporate think tank. Mr. Beatty obtained his Bachelor of Science in Mathematics with a minor in Economics from the University of South Alabama in 1975. He obtained his Masters in Business Administration from the University of New Orleans in 1997.
Robin L. Carmichael, President & Chief Operating Officer
Robin L. Carmichael was appointed our President in February of 2015 and has been our Chief Operating Officer in January 2011. Ms. Carmichael joined the Company in October 2007 as our Vice President of Marketing and Business Development. Prior to joining Helix, Ms. Carmichael most recently served as Chief Operating Officer of DERMAdoctor, Inc., a prestige skin company specializing in over-the-counter drugs and cosmeceuticals. She was Vice President of Marketing with ProCyte Corporation and Photomedex, Inc. following its acquisition of ProCyte in 2005, where she held a number of product marketing positions prior to her appointment as Vice President of Marketing in 1998. During her tenure at ProCyte, she developed and launched seven major product lines and created several new brands. In addition, she established the international distribution business and was actively involved with the various licensing partners. Ms. Carmichael has over 25 years of sales and marketing experience having held a number of regional and national sales positions in the life science and medical device companies, including Baxter Healthcare. She holds a Bachelor of Science in Nursing from Seattle University and attended the UCLA Anderson Graduate School of Executive Management. She is a recognized speaker and author on numerous topics, including peptides, cosmetic surgery and skin care and is a member of Cosmetic Executive Women.
Dr. Lijuan Zhang, Senior Director of R&D Innovation
Dr Lijuan Zhang is an internationally recognized scientist and the Senior Director of R & D Innovation at Helix BioMedix, Inc. She is responsible for the development of new technologies for the aesthetic, dermatology and medical markets. Her leading-edge work has focused on the molecular modulation of the innate immune system to improve skin’s function, appearance, integrity and health. These efforts have resulted in the development of the Company’s patented Smartpeptides® technology, a new and effective way to improve skin health. Dr Zhang has authored over 38 peer reviewed papers and book chapters, presented at numerous international scientific conferences and is an inventor on over 42 patents and patent applications. Dr Zhang has a B.Sc. in microbiology from Northwestern University, China, a M.Sc. in molecular biology from the Chinese Academy of Science and Technology, Beijing and she received her doctorate from the University of Turku, Finland in 1996 followed by post-doctoral fellowships at the University of British Columbia, Canada. Dr Zhang has been a dedicated member of the Helix BioMedix team since 2001.